Celebrating National Doctors’ Day

March 30th is celebrated annually as National Doctors’ Day in the U.S.!

The annual observance, which began in 1933, is aimed at recognizing hard-working physicians who help save and make a true difference in the lives of patients everywhere. Today, we continue to celebrate medical advancements and doctors who’ve given back to their community through their knowledge, expertise and compassion

In honor of National Doctors’ Day, we invite you to submit a virtual heartfelt note below to let your oncologist know how much you appreciate their hard work! Your thoughtful words of gratitude will be sure to put a smile on their face. To view a complete list of our oncologists and get started with care, click here.

Dr. Daniel Huang Receives 2021 Top Doctor Award

We are proud to announce The Oncology Institute’s Medical Director, Daniel Huang, MD, was named 2021 Top Doctor!

Each year, the Orange County Medical Association recognizes the most accomplished and caring physicians that serve the Orange County area. The 2021 cohort recognized a total of 669 O.C. physicians that provide outstanding and compassionate care. The physicians recognized for this award were featured in Orange Coast Magazine’s Top Doctors Issue for 2021.

Dr. Huang was recognized for his excellence in Hematology/Oncology. So many patients and their families lives have been positively impacted thanks to the level of dedication and care that he provides day-to-day. Congratulations on this well-deserved accolade!

To get started with treatment with Dr. Huang, click here.

About Dr. Huang

Born and raised on the East Coast, Dr. Daniel Huang earned his B.S. in biology from Cornell University and his MD from the Mount Sinai School of Medicine. He completed his internship and residency in internal medicine at Cedars-Sinai Medical Center in Los Angeles and his fellowship in hematology and oncology at UCLA-Olive View Medical Center. During his training, Dr. Huang was active in research at the Louis Warschaw Prostate Cancer Center and UCLA-Olive View Medical Center, studying the links between obesity and outcomes in patients with prostate cancer and breast cancer.

Prior to joining The Oncology Institute of Hope and Innovation, Dr. Huang spent two years in private practice in Newport Beach, California. Through his training and private practice, he has gained a wealth of clinical experience in oncology and hematology.

Patient Philosophy

Dr. Huang endeavors to find the intersection between science and compassion in caring for his patients. He seeks to design personalized treatment strategies for each individual while helping them maintain the highest possible quality of life. Dr. Huang knows that the doctor-patient relationship in oncology is unlike any other and strives to build a relationship based on trust and mutual respect. He enjoys and makes use of every opportunity to educate his patients so that they are informed and empowered during their care journey.

Multiple Myeloma Awareness Month

March is Multiple Myeloma Awareness Month. According to the American Cancer Society, Multiple Myeloma is a relatively uncommon cancer, with a lifetime risk of 1 in 132 (0.76%). For those living with Multiple Myeloma, what does this diagnosis mean?

Receiving a cancer diagnosis is never easy, not only for patients, but for their families as well. A cancer diagnosis can bring questions surrounding treatment, day-to-day changes and challenges, mental health and even mortality to the forefront. In addition to delivering state-of-the-art medical care, The Oncology Institute (TOI) believes in providing evidence-based information as part of our patient treatment plan.

Multiple Myeloma

Video: Dr. Amitabha Mazumder, Medical Director, Stem Cell Transplant and Transfusions at The Oncology Institute of Hope and Innovation (TOI) talks Multiple Myeloma, clinical trials, breakthroughs in medicine and how his research has helped improve the quality of life for patients.

What is Multiple Myeloma?

Multiple Myeloma occurs when plasma cells multiply at a rapid rate in the bone marrow, blocking out healthy cells that help to fight infection. The cancerous cells then begin to produce an abnormal antibody called the ‘M protein’ which can trigger symptoms associated with Multiple Myeloma such as bone weakness, severe nerve damage, blood disorders and more.

The American Cancer Society’s estimates for Multiple Myeloma in the United States for 2021 are:

  • About 34,920 new cases will be diagnosed (19,320 in men and 15,600 in women).
  • About 12,410 deaths are expected to occur (6,840 in men and 5,570 in women).

Signs & Symptoms

Multiple Myeloma affects the body in various ways, and while some patients experience little to no symptoms, others may have the following:

  • Low Blood Count
    • This can lead to disorders such as anemia, thrombocytopenia, and leukopenia.
  • Bone Disintegration
    • This type of cancer has profound affect on bone structure — raising calcium levels, causing bone weakness and breaking down bone content.
  • Spinal Cord Compression
    • When the bones weaken, this causes compression in the spine which also leads to severe back pain, numbness, and other nerve damage.
  • Impaired Immune Function & Kidney Problems
    • Due to decreased immunity, pneumonia is common in Multiple Myeloma patients.
    • The proteins in Multiple Myeloma can cause kidney damage that may not show right away, but can cause long-term complications.

For an in-depth review of symptoms from the American Cancer Society, click here.

Disclaimer: Self-diagnosis is never advised, recommended, or certain. If you are experiencing any of the symptoms listed above, consult your primary care physician right away so they can order the proper screening and diagnostic tests for you.

Treatment Options

Depending on the stage of the cancer, treatment options for Multiple Myeloma will vary. There are localized treatments, including surgery or radiation therapy, which are typically offered in the earlier stages of a diagnosis. 

Systemic treatments are also available to patients facing a Multiple Myeloma diagnosis. These treatments may include drug therapy or stem cell transplant.

It’s important to consult your oncology team to go over all options available to you, as well as a best plan of care. To find a Oncology Institute location near you, click here.

Participating in Clinical Trials

Video: Tarek Dessouky, MD, MBA, MPH, Executive Director, Innovative Clinical Research Institute (ICRI) talks about the research arm of The Oncology Institute (TOI), addresses common misconceptions of joining a clinical trial, as well as the benefits of participating in a study.

What is a clinical trial?
A cancer treatment clinical trial is a study conducted with patients in order to evaluate the safety and effectiveness of a new therapy, diagnostic test, or prevention method. A clinical trial also helps determine new ways to use current therapies and drugs.

Clinical trials are conducted in four phases. The FDA requires clinical trials before any kind of medicine can be approved for the general population. Participating in a clinical trial is one way to get access to new, state-of-the-art cancer treatments.

The Innovative Clinical Research Institute (ICRI) at TOI
Innovative Clinical Research Institute (ICRI) is the research arm of The Oncology Institute of Hope and Innovation. They are a leader in the field of cancer clinical trials, a network of compassionate, experienced cancer care specialists.

ICRI was founded in 2011. Since then, they have been committed to advancing and innovating cancer treatment through cutting-edge clinical trials. Their goal is to discover safe and effective cancer treatments to improve the quality of life in cancer patients in the US and around the world.

Patient Resources

Want more information on clinical trials?

Discover a clinical trial that might be right for you

Pinellas Cancer Center Joins The Oncology Institute of Hope and Innovation

ST. PETERSBURG, Fla.–(VIA BUSINESS WIRE)–The Oncology Institute of Hope and Innovation (TOI) announced the acquisition of Pinellas Cancer Center, operated by Dr. Anil Raiker, marking TOI’s entry into the Florida market. TOI is a multi-state cancer care practice dedicated to healing and empowering patients through compassion, innovation, and state-of-the-art medical care. TOI is the largest value-based oncology practice in the U.S., taking accountability for both the quality outcomes as well as the medical costs associated with a population of more than 1 million patients.

Founded in 2007, The Oncology Institute currently operates 40+ locations across 4 states and is adding additional locations and oncologists in the greater Tampa area in 2021.

In reference to joining TOI, Dr. Raiker stated, “As an oncologist, I am always looking for ways to ensure my patients receive the best treatment possible close to their home. By joining TOI, I can bring new, innovative resources to my patients and colleagues.”

TOI is excited to bring their robust service offering to the greater Tampa area, including:

  • A leading clinical research program offering patients access to more than 100 clinical trials.
  • Comprehensive dispensary and pharmacy services to offer convenience and savings to patients receiving oral chemotherapeutics.
  • A care management program which helps patients navigate a complex healthcare system.
  • A state-of-the-art website with educational resources, scheduling capabilities, and a convenient patient portal.

TOI CEO Brad Hively shared, “Dr. Raiker is respected by his colleagues and beloved by his patients for the compassionate care he’s provided to his patients for more than 20 years. We are thrilled to be welcoming him and his team to TOI.”

To schedule an appointment or view details about the St. Petersburg clinic, click here.